DECT-Detected Monosodium Urate Deposits Linked With Bone Erosion in Gout
DECT findings appeared more prognostic than serum uric acid levels alone.
Diagnosis & Disease Information
Benzbromarone vs Allopurinol for Hyperuricemia May Reduce CKD Risk
Benzbromarone, a urate-lowering drug, appeared effective among patients with high serum uric acid levels who had no evidence of gout flares.
Febuxostat Reduces Contrast-Induced Acute Kidney Injury in Stage 3 CKD
Patients with stage 3 chronic kidney disease are at increased risk for contrast-induced acute kidney injury.
Using ULT to Achieve Target Serum Urate Levels Linked to Lower Fracture Risk in Gout
Researchers evaluated effect of lowering serum urate levels to a target level on fracture risk among patients with gout.
Colchicine Use in Gout Not Associated With Higher Cardiovascular Event Risk
Researchers studied the effect of colchicine on cardiovascular outcomes among patients with gout with and without coronary artery disease.
Kidney Stones Form in Nearly 2% of Kidney Transplant Recipients
The kidney stone rate appears to have risen among kidney transplant recipients over the past 2 decades, according to investigators.
Allopurinol May Cut Risk for Neurodegenerative Diseases
Allopurinol linked to 13 to 34% lower risk for Parkinson disease, Alzheimer disease, ALS
Gout Burden Increasing Among Asians in the United States
A recent study is the first to include Asians when examining gout prevalence in the United States.
Dapagliflozin Reduces Serum Uric Acid in Advanced Chronic Kidney Disease
The effects of SGLT2 inhibitors on serum uric acid do not appear to depend on kidney function or diabetes status.
Uric Acid Thresholds That Predict Risk of Kidney Failure, Death Identified
The relationship between current serum uric acid levels and death followed a U-shape.
- Loading...
Loading...
Next post in Hyperuricemia
Loading... 
Loading...